Recently, genome-wide analysis and whole-exome sequencing demonstrated that every ETV6/RUNX1-positive ALL patient could have multiple mutations, underscoring the heterogeneity of this subgroup [13, 14]. The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.